Will Yakowicz, Forbes Staff

Author's posts

With A $120 Million War Chest, Brightseed Is Unlocking The Fat-Fighting Power Of Hemp

The AI-powered company is unlocking the hidden healing potential of plants by finding active compounds that could target specific conditions. Next up: diabetes and sleep disorders.

Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip

The Boston-based neuroscience startup raised $70 million to turn its patented molecules based on classic psychedelic drugs into medicine.

Psychedelic Drug Company MindMed Applies For Nasdaq Up-Listing

If approved, MindMed could become the second psychedelic drug development company listed on Nasdaq.